27.06.2026 – 15:18:59 | boerse-global.de
New genetic insights, simpler diagnostic methods, and surprising findings related to nutrition are changing the understanding of chronic inflammatory bowel diseases (IBD).
Genetic Mutation Found: Cause of Crohn’s Disease in Children
An international team led by Ludwig Maximilians University in Munich has identified a specific genetic cause of Crohn’s disease in children. A mutation in the BIRC3 gene results in functional loss and dysregulation of the RIPK1 signaling pathway.
The researchers analyzed data from 14 affected children across ten families. They suspect that this signaling pathway could also play a central role in more common forms of Crohn’s disease. This discovery offers a deeper understanding of disease development and could serve as a foundation for targeted therapies. The findings were published in the journal Gastroenterology.
Blood Test Instead of Colonoscopy: New Diagnostics for Children
A groundbreaking blood test is now able to detect Crohn’s disease in children with an accuracy of 80-90%, without the need for a colonoscopy. This non-invasive test identifies four specific proteins that indicate the disease, providing insights into the genetic background but does not constitute a formal medical diagnosis.
In pediatric gastroenterology, a breakthrough is on the horizon: a new blood proteomic signature identifies IBD in children with remarkable accuracy. This method is significantly less invasive compared to traditional diagnostic approaches.
The Role of Protein Sources in Disease Progression
Moreover, nutrition plays a more critical role than previously thought. Recent studies in mouse models indicate that beef protein exacerbates inflammatory reactions in the gut, while pea protein appears to be much milder in effect. Urolithin A has shown potential in protecting the gut barrier, and dietary fibers promote the production of butyrate, which is essential for regulating T-cell production.
In light of these findings, the CONSUMER INITIATIVE calls for increased dialogue among policymakers, trade representatives, and industry to enhance the Nutri-Score framework. Currently, there are over 1,040 users registered with more than 1,550 brands. Improvements to the algorithm and broader acceptance of voluntary labeling could facilitate healthier food choices for consumers—especially for those with food intolerances or chronic bowel diseases.
This emerging trend toward less invasive diagnostic methods and better understanding of genetic factors holds promise for improving the quality of life for individuals facing Crohn’s disease.
